Finance

Lists
Why is 539730 down 3,36%?
Dive Deeper
539730:BOM
Fredun Pharmaceuticals Ltd
1 459,00 ₹
-3,36%
(-50,65) 1D
15 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539730...
Open
1 535,05 ₹
High
1 535,05 ₹
Low
1 420,10 ₹
Mkt. cap
24,41 млрд
Avg. vol.
18,64 мың
Volume
11,77 мың
P/E ratio
54,42
52-wk high
1 666,35 ₹
52-wk low
454,05 ₹
EPS
26,81 ₹
Shares outstanding
3,99 млн
No. of employees
736
Open
1 535,05 ₹
High
1 535,05 ₹
Low
1 420,10 ₹
Mkt. cap
24,41 млрд
Avg. vol.
18,64 мың
Volume
11,77 мың
P/E ratio
54,42
52-wk high
1 666,35 ₹
52-wk low
454,05 ₹
EPS
26,81 ₹
Shares outstanding
3,99 млн
No. of employees
736
News stories
From web sources and news partners
About Fredun Pharmaceuticals Ltd
CEO-
Employees736
Founded1987
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 13 там.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
2,28 млрд / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,44 млрд
1,60 млрд
2,13 млрд
2,28 млрд
Cost of goods sold
1,09 млрд
1,15 млрд
1,60 млрд
1,77 млрд
Cost of revenue
1,09 млрд
1,15 млрд
1,60 млрд
1,77 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82,99 млн
81,46 млн
484,22 млн
71,21 млн
Operating expense
163,40 млн
210,93 млн
270,90 млн
216,29 млн
Total operating expenses
1,25 млрд
1,36 млрд
1,87 млрд
1,99 млрд
Operating income
187,30 млн
235,55 млн
252,32 млн
286,78 млн
Other non operating income
17,06 млн
9,97 млн
-49,65 млн
4,92 млн
EBT including unusual items
127,05 млн
140,02 млн
112,48 млн
205,52 млн
EBT excluding unusual items
127,05 млн
140,02 млн
112,48 млн
205,52 млн
Income tax expense
32,74 млн
35,24 млн
53,02 млн
74,20 млн
Effective tax rate
25,77%
25,17%
47,14%
36,10%
Other operating expenses
61,48 млн
111,63 млн
-244,82 млн
109,37 млн
Net income
94,32 млн
104,78 млн
59,45 млн
131,32 млн
Net profit margin
6,57%
6,55%
2,80%
5,77%
Earnings per share
-
-
-
-
Interest and investment income
-
-
6,60 млн
-
Interest expense
-77,31 млн
-105,50 млн
-126,75 млн
-86,18 млн
Net interest expenses
-77,31 млн
-105,50 млн
-120,15 млн
-86,18 млн
Depreciation and amortization charges
18,93 млн
17,84 млн
31,50 млн
35,71 млн
EBITDA
203,86 млн
247,83 млн
272,79 млн
307,24 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары